Vytala
4 known investors
Find your way into Vytala
349 people in our graph share verified history with the Vytala team — schools, employers, funds. One of them is your warm intro.
Vyas Ramananunlockedknows Jim O'Connell · together at The Wharton School (overlapped)
×10knows the team · via The Wharton School
knows the team · via Vytala
Vytala develops a plant-based medical food using its Lym-X-Sorb lipid technology to improve absorption of dietary fat, choline, and essential fatty acids in patients with fat malabsorption from conditions such as cystic fibrosis and pancreatic insufficiency. The product aims to reduce GI symptoms and support weight, growth, and nutrient status without complex diets or medications, and is reimbursable through CMS.
Founders & leadership
JO
Jim O'ConnellinCEO, FounderFounder of Vytala, a medical food company developing structured lipid technology for fat malabsorption. O'Connell has 25+ years of experience in startups and Fortune 500 companies, with a background in advising and board service at startups and nonprofits.
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountPre-SeedSep 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Vytala went on to found or lead other companies.
In the news
Frequently asked questions
- What does Vytala do?
- Vytala develops a plant-based medical food using its Lym-X-Sorb lipid technology to improve absorption of dietary fat, choline, and essential fatty acids in patients with fat malabsorption from conditions such as cystic fibrosis and pancreatic insufficiency. The product aims to reduce GI symptoms and support weight, growth, and nutrient status without complex diets or medications, and is reimbursable through CMS.
- Who founded Vytala?
- Vytala was founded by Jim O'Connell.
- Who are Vytala's investors?
- Vytala's investors include Robin Hood Ventures, Delaware Crossing Investor Group, The MBA Fund, Ulu Ventures.